Clinical trial
Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in…
NCT00312832 · Hospital Clinic of Barcelona, Other · Completed
Key facts
| NCT number | NCT00312832 |
|---|---|
| Title | Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy |
| Official title | A Randomized Open Label Study Comparing the Impact of Reducing the Dose of Stavudine Versus Switching to Tenofovir on Plasma Lipids, Body Composition and Mitochondrial Function in HIV-Infected Patients Receiving Antiretroviral Therapy |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Lipoatrophy |
| Intervention type | Drug |
| Interventions | switching, dose reduction |
| Enrollment | 60 |
| Start date | Jan 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Apr 11, 2006 |
| Last update posted | Oct 24, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: